Skip to Content

WPI 2266 (Acitretin 25 mg)

Pill with imprint WPI 2266 is Brown & Yellow, Capsule-shape and has been identified as Acitretin 25 mg. It is supplied by Actavis Pharma, Inc..

Acitretin is used in the treatment of psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2266

Acitretin

Imprint
WPI 2266
Strength
25 mg
Color
Brown & Yellow
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antipsoriatics
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-2266
Inactive Ingredients
maltodextrin, sodium ascorbate, microcrystalline cellulose, gelatin, sodium lauryl sulfate, titanium dioxide, ferric oxide red, ferric oxide yellow, shellac, ferrosoferric oxide, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.